But ridding the planet of curable and preventable tuberculosis will tax the world’s existing resources.
A TB patient finally gets a disability grant and a woman has free access to the world's most expensive drug.
A report notes that TB rates sky-rocketed in the 1990s fuelled by the HIV epidemic, and warns of a similar situation with diabetes-related TB.
This week it was the mining companies' turn to tell the court why they can't be held responsible for the suffering of thousands of former mineworkers.
A UCT study says counselling is needed to keep tuberculosis sufferers on treatment, without which they risk developing more dangerous forms of TB.
Initiatives in the past four years have greatly increased inmates’ access to healthcare.
The situation of detainees in remand is so bad, it exceeds the punishment of incarceration.
SA’s disability allowance eases the financial and emotional burden of people with tuberculosis.
A private-public partnership is gaining ground in the fight against the disease in the city's slums.
Workers afflicted with silicosis and/or TB launch historic class action lawsuit for compensation.
Poor patients will be the biggest casualty if the National Health Laboratory Service collapses.
New research has bad news for millions of South Africans with high blood sugar: they are three times more likely to develop active tuberculosis.
Compromising hopes of containing the disease, latent TB remains dormant for life for most people.
A study has found that child-focused interventions have significantly reduced HIV-infection rates in children under the age of five.
SA’s status as the country with the highest incidence of tuberculosis (TB) has spurred local research into prevention strategies and cures.
Research suggests that taking HIV medication while CD4 counts are higher than 350 does not reduce mortality in those who are co-infected.
Less than half of those treated for resistant strains of TB survive. It's just not good enough.
Patients with drug resistant TB could benefit from a new drug regimen, which will be tested in clinical trials this year.
New drugs are working on XDR-TB – but must be strictly controlled to prevent further resistance.